Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company 13therapeutics Inc.
DescriptionPro-inflammatory cytokine inhibitor
Molecular Target Toll-like receptor 4 (TLR4) ; Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) inhibitor; Toll-like receptor 4 (TLR4) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentDiscovery
Standard IndicationAtherosclerosis
Indication DetailsTreat atherosclerosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today